RETRACTED ARTICLE: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

Platinum drugs are the frontline therapy in many carcinomas, including high-grade serous ovarian cancers. Clinically, high-grade serous carcinomas have an apparent complete response to carboplatin, but tumors invariably recur and response to platinum drugs diminishes over time. Standard of care proh...

Descripción completa

Detalles Bibliográficos
Autores principales: La, V., Fujikawa, R., Janzen, D. M., Nunez, M., Bainvoll, L., Hwang, L., Faull, K., Lawson, G., Memarzadeh, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551455/
https://www.ncbi.nlm.nih.gov/pubmed/28804784
http://dx.doi.org/10.1038/s41698-017-0008-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551455/
https://www.ncbi.nlm.nih.gov/pubmed/28804784
http://dx.doi.org/10.1038/s41698-017-0008-z

Ejemplares similares